Core Insights - Holzer & Holzer, LLC is investigating whether Sanara MedTech Inc. complied with federal securities laws following the announcement of a strategic realignment that included discontinuing operations of Tissue Health Plus to improve operating efficiency and reallocate resources to its core surgical business [1] - The announcement led to a decline in Sanara's stock price [1] Company Overview - Sanara MedTech Inc. is publicly traded on NASDAQ under the ticker SMTI [1] - The company is focusing on enhancing its core surgical business by discontinuing less efficient operations [1] Legal Context - Holzer & Holzer, LLC is a law firm that specializes in representing shareholders and investors in securities litigation, including class action and derivative litigation [3] - The firm has a history of recovering significant amounts for shareholders affected by corporate misconduct [3]